about
Exon skipping and dystrophin restoration in patients with Duchenne muscular dystrophy after systemic phosphorodiamidate morpholino oligomer treatment: an open-label, phase 2, dose-escalation studyClinical utility of serum biomarkers in Duchenne muscular dystrophyMetabogenic and Nutriceutical Approaches to Address Energy Dysregulation and Skeletal Muscle Wasting in Duchenne Muscular DystrophyNon-invasive MRI and spectroscopy of mdx mice reveal temporal changes in dystrophic muscle imaging and in energy deficitsMusculoskeletal simulation can help explain selective muscle degeneration in Duchenne muscular dystrophy.Magnetic resonance imaging of pediatric muscular disorders: recent advances and clinical applications.Comparison of dixon and T1-weighted MR methods to assess the degree of fat infiltration in duchenne muscular dystrophy patients.Chemical shift-based MRI to measure fat fractions in dystrophic skeletal muscle.Heterogeneity of muscle fat infiltration in children with spina bifida.Multi-parametric MRI characterization of healthy human thigh muscles at 3.0 T - relaxation, magnetization transfer, fat/water, and diffusion tensor imaging.Quantitative NMRI and NMRS identify augmented disease progression after loss of ambulation in forearms of boys with Duchenne muscular dystrophy.Evaluation of muscular changes by ultrasound Nakagami imaging in Duchenne muscular dystrophy.Generation of muscular dystrophy model rats with a CRISPR/Cas system.A phase 1/2a follistatin gene therapy trial for becker muscular dystrophy.Longitudinal measurements of MRI-T2 in boys with Duchenne muscular dystrophy: effects of age and disease progressionQuantitative T2 combined with texture analysis of nuclear magnetic resonance images identify different degrees of muscle involvement in three mouse models of muscle dystrophy: mdx, Largemyd and mdx/Largemyd.Magnetic Resonance Assessment of Hypertrophic and Pseudo-Hypertrophic Changes in Lower Leg Muscles of Boys with Duchenne Muscular Dystrophy and Their Relationship to Functional Measurements.Activation of non-myogenic mesenchymal stem cells during the disease progression in dystrophic dystrophin/utrophin knockout mice.Longitudinal Evaluation of Muscle Composition Using Magnetic Resonance in 4 Boys With Duchenne Muscular Dystrophy: Case Series.Muscle MRI reveals distinct abnormalities in genetically proven non-dystrophic myotonias.Multicenter prospective longitudinal study of magnetic resonance biomarkers in a large duchenne muscular dystrophy cohort.Porcine Zygote Injection with Cas9/sgRNA Results in DMD-Modified Pig with Muscle Dystrophy.Treatment with L-citrulline in patients with post-polio syndrome: study protocol for a single-center, randomised, placebo-controlled, double-blind trial.Use of skeletal muscle MRI in diagnosis and monitoring disease progression in Duchenne muscular dystrophy.Ongoing therapeutic trials and outcome measures for Duchenne muscular dystrophy.Magnetic Resonance Monitoring of Disease Progression in mdx Mice on Different Genetic Backgrounds.Spatially localized phosphorous metabolism of skeletal muscle in Duchenne muscular dystrophy patients: 24-month follow-up.Myopathology in times of modern imaging.Longitudinal MRI quantification of muscle degeneration in Duchenne muscular dystrophy.Striated muscle function, regeneration, and repairMagnetic resonance imaging patterns of muscle involvement in genetic muscle diseases: a systematic review.Longitudinal functional and NMR assessment of upper limbs in Duchenne muscular dystrophy.Progress toward Gene Therapy for Duchenne Muscular Dystrophy.Muscle MRI in patients with long-chain fatty acid oxidation disorders.Follistatin Gene Therapy for Sporadic Inclusion Body Myositis Improves Functional Outcomes.Correction of the Exon 2 Duplication in DMD Myoblasts by a Single CRISPR/Cas9 System.T₂ mapping provides multiple approaches for the characterization of muscle involvement in neuromuscular diseases: a cross-sectional study of lower leg muscles in 5-15-year-old boys with Duchenne muscular dystrophy.Improving translational studies: lessons from rare neuromuscular diseases.Muscle MRI and functional outcome measures in Becker muscular dystrophy.Contrast-Enhanced Near-Infrared Optical Imaging Detects Exacerbation and Amelioration of Murine Muscular Dystrophy.
P2860
Q24616493-7A81D303-ABB8-4ECE-B685-5444C6385A26Q26751261-33D88E7F-AB7B-43F9-9607-6666B660B4DDQ26772002-FFEB4CF6-DF32-4DFE-912A-225AA0158377Q28544896-B8F859AF-011F-466A-B277-826E22508F39Q30300638-35F7DE7B-1770-4E3E-BC97-CFFDEBBCE234Q30441878-0FBDA82F-6178-4D2A-8C93-8EFC0FE7A870Q30584754-E9500722-28BF-4873-9B51-DF01E4242152Q30665063-BC75B742-E102-497E-9D3E-B82DFD6E1AB9Q30685657-4E652315-3BDB-421D-9621-85CF4BA7F203Q30838955-B252AAFD-F097-4D83-A4B6-2531F4EA47B1Q30983066-D88B04C4-00E6-4233-BF8C-68B42D65AD7EQ33860859-4CEE1599-C42C-4B31-87F6-3E4F11EF0C47Q33868949-099A198A-8BAF-461B-9575-9FE60CFCDE37Q34443876-4A40187E-2431-4EEE-ABD4-A950A5F7AD63Q34777673-DA79E7A9-E5DF-441B-BCFB-7F567952490AQ35117796-D10E407E-373A-4F8E-A20D-654C24888882Q35671985-5B4ED80D-B529-445E-8F84-32BD2439F19EQ35693925-8FB3ABC9-8F6B-47ED-BF5D-0313797F4B40Q35837371-DD8BAE31-A7C6-4069-A26C-C8309E4A6181Q37098400-65EC99AD-E75B-4248-9E36-5C292E03E2F1Q37114363-B5BA2239-8F08-408C-B68E-6ED16926E738Q37377344-47AB87B6-E763-4DAA-B971-320C84F91060Q37690071-E19466BD-C58C-4C88-B810-6AFE5E2B3665Q37975308-88033C78-605B-49DF-880F-01DB851C3456Q38115148-882A3B90-FFDE-4EA8-9495-BCDD84934951Q38615889-231520F4-0E4D-4676-8466-8CA7D48B5651Q38649230-ADC2B7EC-829D-42FB-AB9E-F70704380836Q38767197-4287E371-38E4-4853-8A09-BC2B358BBFBDQ38823382-B3945B91-94DC-4895-B95B-3A3E95BB8207Q38857890-4B8C9917-A37B-446A-9AAF-389AFCE161B9Q39020409-17B1D9AB-061E-4446-B9E5-A79A960C337EQ39213123-87BCDD2F-EA54-4166-90AE-84743190F784Q39246797-16357078-9013-40D9-BFE3-0451F5ADFCE3Q39301323-9530D83B-1C87-4E31-AA45-601FC07C6CA0Q40299150-A66790F7-8EE4-4B9A-9CEA-2D87889EBFA5Q42094546-74C78196-70E1-4E40-BB6E-A67F25DD4978Q43059823-88641538-9F24-419B-A01E-47C736D3DF6CQ43214157-AF60154D-7423-4956-AD39-961806F860A1Q47102881-1E3B0A33-B868-459E-AC94-3B2A222BFB58Q47561363-47371DDE-AD3C-4A72-841F-EFF7D875EDC1
P2860
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Muscle histology vs MRI in Duchenne muscular dystrophy.
@ast
Muscle histology vs MRI in Duchenne muscular dystrophy.
@en
Muscle histology vs MRI in Duchenne muscular dystrophy.
@nl
type
label
Muscle histology vs MRI in Duchenne muscular dystrophy.
@ast
Muscle histology vs MRI in Duchenne muscular dystrophy.
@en
Muscle histology vs MRI in Duchenne muscular dystrophy.
@nl
prefLabel
Muscle histology vs MRI in Duchenne muscular dystrophy.
@ast
Muscle histology vs MRI in Duchenne muscular dystrophy.
@en
Muscle histology vs MRI in Duchenne muscular dystrophy.
@nl
P2093
P2860
P1433
P1476
Muscle histology vs MRI in Duchenne muscular dystrophy.
@en
P2093
A Y Manzur
H Jungbluth
J A Gosalakkal
P2860
P304
P356
10.1212/WNL.0B013E318208811F
P407
P577
2011-01-01T00:00:00Z